ArticleHeliyon2024

Implications of baseline glycemic control by plasma glycated hemoglobin A1c on adverse outcomes in patients with coronary heart disease and type 2 diabetes mellitus: Results from the PROMISE study.

Xiao-Fang Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.